Alaska 2025-2026 Regular Session

Alaska House Bill HB195 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	HB0195a -1- HB 195
3	3	New Text Underlined [DELETED TEXT BRACKETED]
4	4
5	5	34-LS0909\A
6	6
7	7
8	8
9	9
10	10
11	11	HOUSE BILL NO. 195
12	12
13	13	IN THE LEGISLATURE OF THE STATE OF ALASKA
14	14
15	15	THIRTY-FOURTH LEGISLATURE - FIRST SESSION
16	16
17	17	BY REPRESENTATIVE MINA
18	18
19	19	Introduced: 4/15/25
20	20	Referred: Health and Social Services, Finance
21	21
22	22
23	23	A BILL
24	24
25	25	FOR AN ACT ENTITLED
26	26
27	27	"An Act relating to the prescription and administration of drugs and devices by 1
28	28	pharmacists; relating to reciprocity for pharmacists; and providing for an effective 2
29	29	date." 3
30	30	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF ALASKA: 4
31	31	* Section 1. AS 08.80.030(b) is amended to read: 5
32	32	(b) In order to fulfill its responsibilities, the board has the powers necessary 6
33	33	for implementation and enforcement of this chapter, including the power to 7
34	34	(1) elect a president and secretary from its membership and adopt rules 8
35	35	for the conduct of its business; 9
36	36	(2) license by examination or by license transfer the applicants who are 10
37	37	qualified to engage in the practice of pharmacy; 11
38	38	(3) assist the department in inspections and investigations for 12
39	39	violations of this chapter, or of any other state or federal statute relating to the practice 13
40	40	of pharmacy; 14 34-LS0909\A
41	41	HB 195 -2- HB0195a
42	42	New Text Underlined [DELETED TEXT BRACKETED]
43	43
44	44	(4) adopt regulations to carry out the purposes of this chapter; 1
45	45	(5) establish and enforce compliance with professional standards and 2
46	46	rules of conduct for pharmacists engaged in the practice of pharmacy; 3
47	47	(6) determine standards for recognition and approval of degree 4
48	48	programs of schools and colleges of pharmacy whose graduates shall be eligible for 5
49	49	licensure in this state, including the specification and enforcement of requirements for 6
50	50	practical training, including internships; 7
51	51	(7) establish for pharmacists and pharmacies minimum specifications 8
52	52	for the physical facilities, technical equipment, personnel, and procedures for the 9
53	53	storage, compounding, and dispensing of drugs or related devices, and for the 10
54	54	monitoring of drug therapy, including independent monitoring of drug therapy; 11
55	55	(8) enforce the provisions of this chapter relating to the conduct or 12
56	56	competence of pharmacists practicing in the state, and the suspension, revocation, or 13
57	57	restriction of licenses to engage in the practice of pharmacy; 14
58	58	(9) license and regulate the training, qualifications, and employment of 15
59	59	pharmacy interns and pharmacy technicians; 16
60	60	(10) license and regulate the qualifications of entities and individuals 17
61	61	engaged in the manufacture or distribution of drugs and related devices; 18
62	62	(11) establish and maintain a controlled substance prescription 19
63	63	database as provided in AS 17.30.200; 20
64	64	(12) establish standards for the independent prescribing and 21
65	65	administration of vaccines and related emergency medications under AS 08.80.168, 22
66	66	including the completion of an immunization training program approved by the board 23
67	67	and an epinephrine auto-injector training program under AS 17.22.020(b); 24
68	68	(13) establish standards for the independent prescribing and dispensing 25
69	69	by a pharmacist of an opioid overdose drug under AS 17.20.085, including the 26
70	70	completion of an opioid overdose training program approved by the board; 27
71	71	(14) require that a licensed pharmacist who prescribes, administers, 28
72	72	or dispenses a schedule IA, IIA, IIIA, IVA, or VA controlled substance under 29
73	73	state law or schedule II, III, [OR] IV, or V controlled substance under federal law to a 30
74	74	person in the state register with the controlled substance prescription database under 31 34-LS0909\A
75	75	HB0195a -3- HB 195
76	76	New Text Underlined [DELETED TEXT BRACKETED]
77	77
78	78	AS 17.30.200(n); 1
79	79	(15) establish the qualifications and duties of the executive 2
80	80	administrator and delegate authority to the executive administrator that is necessary to 3
81	81	conduct board business; 4
82	82	(16) license and inspect the facilities of pharmacies, manufacturers, 5
83	83	wholesale drug distributors, third-party logistics providers, and outsourcing facilities 6
84	84	located outside the state under AS 08.80.159; 7
85	85	(17) license Internet-based pharmacies providing services to residents 8
86	86	in the state; 9
87	87	(18) adopt regulations pertaining to retired pharmacist status. 10
88	88	* Sec. 2. AS 08.80.110 is amended to read: 11
89	89	Sec. 08.80.110. Qualifications for licensure by examination. An applicant 12
90	90	for licensure as a pharmacist shall 13
91	91	(1) be fluent in the reading, writing, and speaking of the English 14
92	92	language; 15
93	93	(2) be a graduate of a college in a degree program approved by the 16
94	94	board; 17
95	95	(3) pass an examination or examinations given by the board or 18
96	96	acceptable to the board under the score transfer process administered by the National 19
97	97	Association of Boards of Pharmacy; 20
98	98	(4) have completed internship training or another program that has 21
99	99	been approved by the board or demonstrated to the board's satisfaction that the 22
100	100	applicant has experience in the practice of pharmacy that meets or exceeds the 23
101	101	minimum internship requirements of the board; and 24
102	102	(5) receive education in pain management and opioid use and 25
103	103	addiction, unless the applicant has demonstrated to the satisfaction of the board 26
104	104	that the applicant does not currently hold a valid federal Drug Enforcement 27
105	105	Administration registration number; an applicant may include past professional 28
106	106	experience or professional education as proof of professional competence. 29
107	107	* Sec. 3. AS 08.80.145 is amended to read: 30
108	108	Sec. 08.80.145. Reciprocity; license transfer. If another jurisdiction allows 31 34-LS0909\A
109	109	HB 195 -4- HB0195a
110	110	New Text Underlined [DELETED TEXT BRACKETED]
111	111
112	112	licensure in that jurisdiction of a pharmacist licensed in this state under conditions 1
113	113	similar to those in this section, the board may license as a pharmacist in this state a 2
114	114	person licensed as a pharmacist in the other jurisdiction if the person 3
115	115	(1) submits a written application to the board on a form required by the 4
116	116	board; 5
117	117	(2) is at least 18 years of age; 6
118	118	(3) possesses at the time of the request for licensure as a pharmacist in 7
119	119	this state the qualifications necessary to be eligible for licensure in this state; 8
120	120	(4) has engaged in the practice of pharmacy for at least one year 9
121	121	immediately before applying for a license under this section; 10
122	122	(5) presents proof satisfactory to the board that the person is currently 11
123	123	licensed as a pharmacist in the other jurisdiction and does not currently have a 12
124	124	pharmacist license suspended, revoked, or otherwise restricted except for failure to 13
125	125	apply for renewal or failure to obtain the required continuing education credits; 14
126	126	(6) has passed an examination approved by the board that tests the 15
127	127	person's knowledge of Alaska laws relating to pharmacies and pharmacists and the 16
128	128	regulations adopted under those laws; [AND] 17
129	129	(7) meets the requirements of AS 08.80.110(5); and 18
130	130	(8) pays all required fees. 19
131	131	* Sec. 4. AS 08.80.165 is amended to read: 20
132	132	Sec. 08.80.165. Continuing education requirements. The board shall 21
133	133	establish requirements for continuing education in pharmacy that must be satisfied 22
134	134	before a license issued under this chapter may be renewed. The continuing education 23
135	135	requirements must include at least two hours of education in pain management 24
136	136	and opioid use and addiction in the two years preceding an application for 25
137	137	renewal of a license. The board may exempt a licensee from the requirement to 26
138	138	receive at least two hours of education in pain management and opioid use and 27
139	139	addiction if the licensee demonstrates to the satisfaction of the board that 28
140	140	(1) the licensee's practice does not include pain management and 29
141	141	opioid prescription or administration; or 30
142	142	(2) the licensee does not currently hold a valid federal Drug 31 34-LS0909\A
143	143	HB0195a -5- HB 195
144	144	New Text Underlined [DELETED TEXT BRACKETED]
145	145
146	146	Enforcement Administration registration number. 1
147	147	* Sec. 5. AS 08.80.337(a) is amended to read: 2
148	148	(a) A pharmacist may, under a collaborative practice agreement with a written 3
149	149	protocol approved by a practitioner who is not a pharmacist, provide patient care 4
150	150	services. 5
151	151	* Sec. 6. AS 08.80.337(d) is amended to read: 6
152	152	(d) In this section, "patient care services" means medical care services, 7
153	153	including the prescription or administration of a drug or device to a patient, that 8
154	154	are given in exchange for compensation and intended to achieve outcomes related to 9
155	155	the cure or prevention of a disease, elimination or reduction of a patient's symptoms, 10
156	156	or arresting or slowing of a disease process. 11
157	157	* Sec. 7. AS 08.80.337 is amended by adding a new subsection to read: 12
158	158	(e) A pharmacist prescribing or administering a drug or device under this 13
159	159	section shall recognize the limits of the pharmacist's education, training, and 14
160	160	experience and consult with and refer to other practitioners as appropriate. 15
161	161	* Sec. 8. AS 08.80.480(30) is amended to read: 16
162	162	(30) "practice of pharmacy" means the interpretation, evaluation, and 17
163	163	dispensing of prescription drug orders in the patient's best interest; participation in 18
164	164	drug and device selection, drug administration, drug regimen reviews, and drug or 19
165	165	drug-related research; provision of patient counseling and the provision of those acts 20
166	166	or services necessary to provide pharmaceutical care; the independent prescribing, 21
167	167	dispensing, and administration of drugs in accordance with AS 08.80.168; providing 22
168	168	patient care services in accordance with AS 08.80.337; the responsibility for 23
169	169	compounding and labeling of drugs and devices except labeling by a manufacturer, 24
170	170	repackager, or distributor of nonprescription drugs and commercially packaged legend 25
171	171	drugs and devices; proper and safe storage of drugs and devices; and maintenance of 26
172	172	proper records for them; 27
173	173	* Sec. 9. AS 08.80.480 is amended by adding a new paragraph to read: 28
174	174	(40) "opioid" includes the opium and opiate substances and opium and 29
175	175	opiate derivatives listed in AS 11.71.140 and 11.71.160. 30
176	176	* Sec. 10. AS 08.80.337(c) is repealed. 31 34-LS0909\A
177	177	HB 195 -6- HB0195a
178	178	New Text Underlined [DELETED TEXT BRACKETED]
179	179
180	180	* Sec. 11. This Act takes effect January 1, 2026. 1